VRX : Analysis & Opinions

  1. Tuesday Intel: More Volatility Ahead

    September 29, 2015
    Yesterday started the week with a dose of fear as the VIX shot up by almost 17 percent. The index has been consistently trending ...
  2. Citron: 'The Real Problem With Drug Pricing In America Is Forged ...

    September 28, 2015
    Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were down more than 15 percent on Monday. The decline was triggered ...
  3. The 3 Best Investments Bill Ackman Ever Made

    September 2, 2015
    Learn about the three best investments Ackman ever made. Ackman has demonstrated a consistent track record of success in ...
  4. Valeant Pharmaceuticals acquires Sprout Pharmaceuticals

    August 21, 2015
    On August 20, 2015, Valeant Pharmaceuticals (VRX) announced that they entered into definitive agreement to acquire Sprout ...
  5. Want to Beat the Market? Take on Some Risk

    July 8, 2015
    As we head into a sketchy investment environment, you may want to reverse your thinking to find the best opportunities.
  6. Most Important Mergers And Acquisitions Of 2015

    June 15, 2015
    Nearly halfway through the year, 2015 is proving to be a big one for mergers and acquisitions.
  7. Portfolio Manager Minyi Chen On Why Certain Companies Are Likely ...

    May 18, 2015
    Minyi Chen, portfolio manager of AdvisorShares TrimTabs Float Shrink ETF (NYSE: TTFS) said he believes certain companies ...
  8. Four Breakout Stocks To Watch

    February 19, 2014
    These biotechnology and pharmaceutical stocks continue to put in new highs, but indicators are diverging.
  9. After A Sharp Pullback, Is Allergan Pretty Enough?

    July 31, 2013
    Down on fears about generics and the pipeline, the Street may be underestimating Allergan
  10. Abbott Adds Two Promising Products

    July 15, 2013
    Abbott makes two solid growth acquisitions that should address large markets.
  11. Valeant Eyes Bausch & Lomb

    May 28, 2013
    Canadian pharmaceutical company Valeant has made a name for itself through acquisitions. On May 27 it announced that it was ...
  12. A Good Deal For Actavis, But Warner Chilcott Goes A Little Cheap

    May 21, 2013
    Actavis gets a very useful asset, while Warner Chilcott shareholders get a decent exit.
  13. Adasuve Deal Is Very Good For Alexza, But What About Teva?

    May 9, 2013
    Teva's partnership with Alexza looks like an expensive gamble.
  14. Valeant Works Its Mojo With Medicis

    September 7, 2012
    Valeant makes a bold but logical bid for Medicis.
  15. Valeant Pharmaceuticals Int (USA) and Other Healthcare Stocks ...

    August 15, 2012
    The Nasdaq is trading up 0.2%, the S&P 500 has remained steady and the Dow remains relatively unchanged so far today. ...
  16. Novo Nordisk A/S (ADR) and Other Big Movers In Healthcare

    August 14, 2012
    The Nasdaq has climbed 0.6%, the S&P 500 is up 0.3% and the Dow has risen 0.3%, marking a bad morning for the market. ...
  17. Biggest Healthcare Sector Movers for July 3, 2012

    July 3, 2012
    The market is doing well so far today. The Nasdaq has moved up 0.7%; the S&P 500 is up 0.7%; and the Dow has risen 0.6%. ...
  18. Obagi Puts Its Problems Behind It

    May 25, 2012
    A year ago, Obagi Medical Products faced some problems in Texas that presented an investment opportunity. One year later ...
  19. Stocks To Buy On A Market Sell-Off

    March 8, 2012
    A market pullback will create a buying opportuntiy for some of the top performing stocks.
  20. The Salix Story Keeps Improving

    January 18, 2012
    Salix is a great candidate for growth investors.
  21. Can The Big Gains Continue Into 2012?

    January 3, 2012
    Learn the opportunities and risks that await some top performers in 2012.
  22. 2011 In Review - Pharmaceuticals

    December 29, 2011
    2011 was a surprisingly healthy year for drug stocks.
  23. Canada Is Key For A Strong Portfolio

    November 10, 2011
    With the majority of the developed world still facing problems, Canada is beacon of growth.
  24. Covidien's Image Starting To Change

    August 3, 2011
    Find out why Covidien is much better than many investors assume.
Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!